FGF-2 agonist (Buck Institute/Neurobiological Technologies)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFGF-2 agonist (Buck Institute/Neurobiological Technologies)
Drug Alias NameHuntington's disease therapy (Buck Institute/Neurobiological Technologies)Fibroblast growth factor-2 agonist (Buck Institute/Neurobiological Technologies)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBuck Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBuck InstituteNeurobiological Technologies Inc
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A